Name: Alto Neuroscience, Inc. (ANRO) Cash Flow Statement
Creator: FinSpry

Alto Neuroscience Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Alto Neuroscience, Inc. (ANRO) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Operating Activities
Net Income	-61.43	-36.31	-27.71	-9.19
Depreciation & Amortization	0.50	0.37	0.34	0.15
Stock Based Compensation	7.63	2.89	1.76	0.23
Change in Working Capital	4.06	-0.70	4.58	-0.57
Change in Accounts Receivable	0.00	0.00	1.16	-1.29
Change in Accounts Payable	0.52	-0.63	1.01	0.46
Change in Other Working Capital	3.54	-0.07	2.42	0.26
Other Operating Activities	1.81	0.15	0.63	0.13
Net Cash from Operating Activities	-47.42	-33.45	-20.39	-9.26
Investing Activities
Capital Expenditures	-2.08	-0.47	-0.73	-0.68
Net Cash from Investing Activities	-2.08	-0.47	-0.73	-0.68
Financing Activities
Debt Repayment	1.25	0.00	0.00	0.00
Common Stock Issued	137.58	0.18	0.04	0.01
Other Financing Activities	-3.14	-2.05	-0.34	-0.21
Net Cash from Financing Activities	135.69	68.13	43.79	31.69
Summary
Effect of Forex Changes on Cash	-0.01	-0.01	-0.02	-0.05
Net Change in Cash	86.18	34.20	22.64	21.70
Cash at Beginning of Period	82.55	48.34	25.71	4.01
Cash at End of Period	168.73	82.55	48.34	25.71
Free Cash Flow	-49.50	-33.92	-21.13	-9.94
Supplemental Disclosures
Interest Paid	1.00	0.91	0.00	0.00